Unknown OBSERVATIONAL NCT04743388

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

Study of the Kinetics of Antibodies Against SARS-CoV-2 and of Cellular Subpopulations of the Immune System in Volunteers Receiving the BNT162b2 Vaccine or Other Approved Vaccine Against SARS-CoV-2

Sponsor: National and Kapodistrian University of Athens

Conditions COVID-19 Chronic Disease Healthy Volunteers Hematological Malignancies Solid Tumor

Interventions BNT162b2 Other vaccine against SARS-Cov-2

Updated 6 times since 2021 Last updated: Apr 8, 2022 Started: Jan 4, 2021 Primary completion: Aug 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19 and Chronic Disease, this trial is ongoing. The trial is conducted by National and Kapodistrian University of Athens and has accumulated 6 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Recruiting
Dec 2021 — May 2022 [monthly]

Recruiting

▶ Show 1 earlier version

Mar 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National and Kapodistrian University of Athens

Data source: National and Kapodistrian University of Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece